Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine bolus versus low-dose infusion for prevention of pain, nausea, and vomiting after laparoscopic cholecystectomy
IRCT20160307026950N83Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexmedetomidine in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Pain intensity, Dose of additional analgesic administered and 3 more. Started Jul 2026; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20160307026950N83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N83.